Actionable insights — How SpaceX Makes Money

1. Value a multi-segment story by summing the parts, not the headline

1. When a company bundles very different businesses under one ticker, refuse the single blended multiple — split it into segments and value each on its own peer multiple.
2. Use the relevant metric per segment (EBITDA multiple for a cash-generative one, forward-revenue multiple for an early-stage one, an optionality range for the unproven moonshots).
3. Add the parts to a range, then compare that range against the IPO's asking price — the gap is the margin of safety (or the overpayment).

• Any IPO where the blended valuation only works if you accept the most speculative segment at its dream multiple — sum the parts to expose it.

2. Separate an R&D-driven segment loss from a structurally unprofitable one

1. When a segment shows an operating loss, read the notes for the discretionary spend buried inside it (heavy R&D on a pre-revenue product).
2. Add that spend back to see the "steady-state" economics — a business funding a future product can look unprofitable while the core is healthy.
3. Contrast it with a segment whose loss is the running cost of the business as-is — that one is structurally unprofitable, a very different risk.

• A segment that flips to profit the moment you back out a single pre-revenue R&D line — versus one whose loss scales with revenue (the real red flag).

3. Find the cash engine and the cash sink before trusting the story

1. For a "flywheel" narrative, identify which segment actually generates the cash and which consumes it — the story only holds if the engine can fund the sink.
2. Check the engine's margin durability (is ARPU/pricing rising or compressing?) and the sink's burn trajectory (is the loss widening as it scales?).
3. Size the runway: cash on hand plus the raise, divided by the burn rate, tells you how long before the next raise.

• A cash engine with eroding unit economics funding a sink with widening losses — the flywheel can stall before the moonshots pay off.

4. Apply the "IPO = probably overpriced" discipline — let it trade first

1. Treat the IPO price as the seller's number, set when insider information and hype are highest — assume it's optimized for the seller, not the buyer.
2. Map the valuation path (last private round → merger mark → IPO ask) to see how much the number moved on narrative versus fundamentals.
3. Default to the watchlist: let the stock trade for a few quarters so real numbers (and the float's true clearing price) replace the pitch — then decide.

• A valuation that tripled on merger/narrative marks rather than revenue — and the first few quarters of post-IPO prints that test the pitch.

5. Price the founder-premium asymmetry into your skepticism

1. Ask whether the market is capitalizing pre-revenue moonshots (robots, Mars, orbital compute) into the valuation today — and whether it would do so for any other company.
2. Cross-check against peers: do the same speculative bets move a more skeptically-priced rival's stock? If not, you're paying a founder premium.
3. Read the executive pay package — milestone-based mega-grants reveal what the valuation is really being asked to believe (and over what horizon).

• A milestone pay package tied to a multi-trillion market cap — it tells you the valuation is underwriting a story, not a 5-year DCF.

6. Read how a buyer takes exposure — option vs outright stake

1. When a company "invests in" or "ties up" another, check whether it bought shares outright or took an option/warrant with a breakup fee.
2. An option is a cheap, low-commitment bet — it signals interest without conviction, and only converts if the target proves out.
3. Treat embedded options (and large off-balance-sheet contracts) as call options on the upside, not as committed value in the base case.

• Acquisition options and off-backlog mega-contracts dressed up as proven value — discount them to their true (conditional) worth.